NO178134C - Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse - Google Patents

Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse

Info

Publication number
NO178134C
NO178134C NO873273A NO873273A NO178134C NO 178134 C NO178134 C NO 178134C NO 873273 A NO873273 A NO 873273A NO 873273 A NO873273 A NO 873273A NO 178134 C NO178134 C NO 178134C
Authority
NO
Norway
Prior art keywords
preparation
tablet
prolonged release
formulation adjuvant
sustained
Prior art date
Application number
NO873273A
Other languages
English (en)
Norwegian (no)
Other versions
NO873273D0 (no
NO873273L (no
NO178134B (no
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO873273D0 publication Critical patent/NO873273D0/no
Publication of NO873273L publication Critical patent/NO873273L/no
Publication of NO178134B publication Critical patent/NO178134B/no
Publication of NO178134C publication Critical patent/NO178134C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO873273A 1986-08-06 1987-08-05 Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse NO178134C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤

Publications (4)

Publication Number Publication Date
NO873273D0 NO873273D0 (no) 1987-08-05
NO873273L NO873273L (no) 1988-02-08
NO178134B NO178134B (no) 1995-10-23
NO178134C true NO178134C (no) 1996-01-31

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873273A NO178134C (no) 1986-08-06 1987-08-05 Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse

Country Status (11)

Country Link
EP (1) EP0255725B1 (de)
JP (1) JPH0780754B2 (de)
KR (1) KR950002148B1 (de)
AT (1) ATE102480T1 (de)
CA (1) CA1315680C (de)
DE (1) DE3789258T2 (de)
DK (1) DK175798B1 (de)
ES (1) ES2050653T3 (de)
FI (1) FI96480C (de)
NO (1) NO178134C (de)
PH (1) PH25545A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
ATE219931T1 (de) * 1993-10-12 2002-07-15 Mitsubishi Pharma Corp Darmlösliche grannulatkörner enthaltende tablette
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1339395A2 (de) 2000-11-28 2003-09-03 Fmc Corporation Essbare überzugszusammensetzung aus pga (propylenglykolalginat)
MXPA03000985A (es) 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
FR2837100B1 (fr) 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
EP0255725A3 (de) 1991-01-30
DK407287D0 (da) 1987-08-05
PH25545A (en) 1991-08-08
FI96480B (fi) 1996-03-29
ES2050653T3 (es) 1994-06-01
JPS6339811A (ja) 1988-02-20
KR950002148B1 (ko) 1995-03-14
KR880002510A (ko) 1988-05-09
ATE102480T1 (de) 1994-03-15
DE3789258D1 (de) 1994-04-14
FI873407A0 (fi) 1987-08-05
NO873273D0 (no) 1987-08-05
EP0255725A2 (de) 1988-02-10
JPH0780754B2 (ja) 1995-08-30
FI873407L (fi) 1988-02-07
DE3789258T2 (de) 1994-08-11
NO873273L (no) 1988-02-08
EP0255725B1 (de) 1994-03-09
DK407287A (da) 1988-02-07
CA1315680C (en) 1993-04-06
NO178134B (no) 1995-10-23
DK175798B1 (da) 2005-02-28
FI96480C (fi) 1996-07-10

Similar Documents

Publication Publication Date Title
NO884947L (no) Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse.
SE8504720D0 (sv) New drug preparation
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO883612D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin.
IE38602B1 (en) Aryloxyalnolamine derivatives their preparation and use in pharmaceutical compositions
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
PH25545A (en) Sustained release multi-granule tablet
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO177376C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
SE8505569D0 (sv) Enteralt preparat
NO168361C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye adenosinderivater
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
GB1379008A (en) Medicament for the treatment of herpes simplex
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired